Shafa Orthopedic Journal

Published by: Kowsar

Optimal Timing and Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): Literature Review and World Consensus (Part Three)

Javad Parvizi 1 , * , Mohammad Ghazavi 2 , 3 and Members of Pre-op Antibiotics Committee of the Consensus Meeting 4
Authors Information
1 Rothman Institute, Thomas Jefferson University, Philadelphia, PA, USA
2 Scarborough Hospital, Toronto, Ontario, Canada
3 Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR Iran
4 William Arnold MD PhD; Katherine Belden MD; Goran Bicanic; Stefano Bini MD; Fabio Catani MD; Jiying Chen MD PhD; Mohammad Ghazavi MD FRCSC; Karine M. Godefroy MD; Erik Hansen MD; Paul Holham MD; Hamid Hosseinzadeh MD; Kang II Kim MD; Klaus|Kirketerp-Moller MD; Lars Lidgren MD PhD; Jian Hao|Lin MD; Jess H Lonner MD; Christopher Moore MD; Panayiotis Papagelopoulos MD; Lazaros Poultsides MD MSc PhD; Khalid Saleh MD MSC FRCSC MHCM; Julia V Salmon MD; Edward Schwarz PhD; Randi Silibovsky MD (US); Jose Stuyck MD; Markus Vogt MD (International); Annette W Dahl MD; Koji Yamada MD
Article information
  • Shafa Orthopedic Journal: August 28, 2015, 2 (3); e2355
  • Published Online: August 24, 2015
  • Article Type: Review Article
  • Received: December 3, 2014
  • Revised: January 2, 2015
  • Accepted: February 1, 2015
  • DOI: 10.17795/soj-2355

To Cite: Parvizi J, Ghazavi M, Members of Pre-op Antibiotics Committee of the Consensus Meeting . Optimal Timing and Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): Literature Review and World Consensus (Part Three), Shafa Ortho J. 2015 ;2(3):e2355. doi: 10.17795/soj-2355.

Abstract
Copyright © 2015, Iran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty.
  • 2. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24(5): 362-86[DOI][PubMed]
  • 3. Hawn MT, Richman JS, Vick CC, Deierhoi RJ, Graham LA, Henderson WG, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013; 148(7): 649-57[DOI][PubMed]
  • 4. Cantoni L, Glauser MP, Bille J. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Antimicrob Agents Chemother. 1990; 34(12): 2348-53[PubMed]
  • 5. Patel M, Kumar RA, Stamm AM, Hoesley CJ, Moser SA, Waites KB. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol. 2007; 45(10): 3431-3[DOI][PubMed]
  • 6. Manian FA, Griesnauer S. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) is replacing traditional health care-associated MRSA strains in surgical-site infections among inpatients. Clin Infect Dis. 2008; 47(3): 434-5[DOI][PubMed]
  • 7. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1995; 44: 1-13
  • 8. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350(9092): 1670-3[DOI][PubMed]
  • 9. Michel M, Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet. 1997; 349(9069): 1901-6[PubMed]
  • 10. Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006; 88(6): 1231-7[DOI][PubMed]
  • 11. Surgical Site Infection surveillance service. Protocol for surveillance of surgical site infection.
  • 12. Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am. 2009; 91(10): 2480-90[DOI][PubMed]
  • 13. Wiesel BB, Esterhai JL. Musculosketal Infections. 2003; : 115-29[DOI]
  • 14. Merrer J, Desbouchages L, Serazin V, Razafimamonjy J, Pauthier F, Leneveu M. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes. Infect Control Hosp Epidemiol. 2006; 27(12): 1366-71[DOI][PubMed]
  • 15. Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess. 2008; 12(1)-1-147[PubMed]
  • 16. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004; 38(10): 1357-63[DOI][PubMed]
  • 17. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999; 20(4): 250-78[DOI][PubMed]
  • 18. Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2008; 69(4): 337-44[DOI][PubMed]
  • 19. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002; 123(2): 326-32[PubMed]
  • 20. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008; 52(2): 446-51[DOI][PubMed]
  • 21. Spelman D, Harrington G, Russo P, Wesselingh S. Clinical, microbiological, and economic benefit of a change in antibiotic prophylaxis for cardiac surgery. Infect Control Hosp Epidemiol. 2002; 23(7): 402-4[DOI][PubMed]
  • 22. Smith EB, Wynne R, Joshi A, Liu H, Good RP. Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients? J Arthroplasty. 2012; 27(8 Suppl): 55-60[DOI][PubMed]
  • 23. Bull AL, Worth LJ, Richards MJ. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS). Ann Surg. 2012; 256(6): 1089-92[DOI][PubMed]
  • 24. Miller LG, McKinnell JA, Vollmer ME, Spellberg B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol. 2011; 32(4): 342-50[DOI][PubMed]
  • 25. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis. 2001; 7(5): 828-31[DOI][PubMed]
  • 26. Zanetti G, Goldie SJ, Platt R. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis. 2001; 7(5): 820-7[DOI][PubMed]
  • 27. Muralidhar B, Anwar SM, Handa AI, Peto TE, Bowler IC. Prevalence of MRSA in emergency and elective patients admitted to a vascular surgical unit: implications for antibiotic prophylaxis. Eur J Vasc Endovasc Surg. 2006; 32(4): 402-7[DOI][PubMed]
  • 28. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother. 2006; 57(4): 589-608[DOI][PubMed]
  • 29. Elliott RA, Weatherly HL, Hawkins NS, Cranny G, Chambers D, Myers L, et al. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? Eur J Health Econ. 2010; 11(1): 57-66[DOI][PubMed]
  • 30. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011; 171(1): 68-73[DOI][PubMed]
  • 31. Dhadwal K, Al-Ruzzeh S, Athanasiou T, Choudhury M, Tekkis P, Vuddamalay P, et al. Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial. Heart. 2007; 93(9): 1126-33[DOI][PubMed]
  • 32. Patrick S, James C, Ali A, Lawson S, Mary E, Modak A. Vascular surgical antibiotic prophylaxis study (VSAPS). Vasc Endovascular Surg. 2010; 44(7): 521-8[DOI][PubMed]
  • 33. Sewick A, Makani A, Wu C, O'Donnell J, Baldwin KD, Lee GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res. 2012; 470(10): 2702-7[DOI][PubMed]
  • 34. Ritter MA, Barzilauskas CD, Faris PM, Keating EM. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics. 1989; 12(10): 1333-6[PubMed]
  • 35. Cruess RL, Bickel WS, vonKessler KL. Infections in total hips secondary to a primary source elsewhere. Clin Orthop Relat Res. 1975; (106): 99-101[PubMed]
  • 36. Hall AJ. Late infection about a total knee prosthesis. Report of a case secondary to urinary tract infection. J Bone Joint Surg Br. 1974; 56(1): 144-7[PubMed]
  • 37. David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg. 2000; 8(1): 66-74[PubMed]
  • 38. Ritter MA, Fechtman RW. Urinary tract sequelae: possible influence on joint infections following total joint replacement. Orthopedics. 1987; 10(3): 467-9[PubMed]
  • 39. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop Scand. 1992; 63(6): 665-71[PubMed]
  • 40. Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res. 1984; (185): 151-4[PubMed]
  • 41. Waterhouse N, Beaumont AR, Murray K, Staniforth P, Stone MH. Urinary retention after total hip replacement. A prospective study. J Bone Joint Surg Br. 1987; 69(1): 64-6[PubMed]
  • 42. Walton JK, Robinson RG. An analysis of a male population having total hip replacement with regard to urological assessment and post-operative urinary retention. Br J Urol. 1982; 54(5): 519-21[PubMed]
  • 43. Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013; 173(1): 62-8[DOI][PubMed]
  • 44. Irvine R, Johnson BJ, Amstutz HC. The relationship of genitourinary tract procedures and deep sepsis after total hip replacements. Surg Gynecol Obstet. 1974; 139(5): 701-6[PubMed]
  • 45. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974; 291(5): 215-9[DOI][PubMed]
  • 46. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966; 274(21): 1155-61[DOI][PubMed]
  • 47. Jerry GJ, Rand JA, Ilstrup D. Old sepsis prior to total knee arthroplasty. Clin Orthop Relat Res. 1988; (236): 135-40[PubMed]
  • 48. Lee GC, Pagnano MW, Hanssen AD. Total knee arthroplasty after prior bone or joint sepsis about the knee. Clin Orthop Relat Res. 2002; (404): 226-31[PubMed]
  • 49. Larson AN, Hanssen AD, Cass JR. Does prior infection alter the outcome of TKA after tibial plateau fracture? Clin Orthop Relat Res. 2009; 467(7): 1793-9[DOI][PubMed]
  • 50. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med. 1988; 319(6): 321-6[DOI][PubMed]
  • 51. Martinez OV, Civetta JM, Anderson K, Roger S, Murtha M, Malinin TI. Bacteriuria in the catheterized surgical intensive care patient. Crit Care Med. 1986; 14(3): 188-91[PubMed]
  • 52. Schaeffer AJ. Catheter-associated bacteriuria. Urol Clin North Am. 1986; 13(4): 735-47[PubMed]
  • 53. Skelly JM, Guyatt GH, Kalbfleisch R, Singer J, Winter L. Management of urinary retention after surgical repair of hip fracture. CMAJ. 1992; 146(7): 1185-9[PubMed]
  • 54. Donovan TL, Gordon RO, Nagel DA. Urinary infections in total hip arthroplasty. Influences of prophylactic cephalosporins and catheterization. J Bone Joint Surg Am. 1976; 58(8): 1134-7[PubMed]
  • 55. Fitzgerald RJ, Nolan DR, Ilstrup DM, Van Scoy RE, Washington J2, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977; 59(7): 847-55[PubMed]
  • 56. Surin VV, Sundholm K, Backman L. Infection after total hip replacement. With special reference to a discharge from the wound. J Bone Joint Surg Br. 1983; 65(4): 412-8[PubMed]
  • 57. Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg. 2007; 31(12): 2293-9[DOI][PubMed]
  • 58. Lanier ST, Wang ED, Chen JJ, Arora BP, Katz SM, Gelfand MA, et al. The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann Plast Surg. 2010; 64(5): 674-8[DOI][PubMed]
  • 59. Sorensen AI, Sorensen TS. Bacterial growth on suction drain tips. Prospective study of 489 clean orthopedic operations. Acta Orthop Scand. 1991; 62(5): 451-4[PubMed]
  • 60. van den Brand IC, Castelein RM. Total joint arthroplasty and incidence of postoperative bacteriuria with an indwelling catheter or intermittent catheterization with one-dose antibiotic prophylaxis: a prospective randomized trial. J Arthroplasty. 2001; 16(7): 850-5[DOI][PubMed]
  • 61. Oishi CS, Williams VJ, Hanson PB, Schneider JE, Colwell CJ, Walker RH. Perioperative bladder management after primary total hip arthroplasty. J Arthroplasty. 1995; 10(6): 732-6[PubMed]
  • 62. Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res. 2009; 467(7): 1859-67[DOI][PubMed]
  • 63. Brahmbhatt RD, Huebner M, Scow JS, Harmsen WS, Boughey JC, Harris AM, et al. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012; 19(10): 3205-11[DOI][PubMed]
  • 64. Phillips BT, Wang ED, Mirrer J, Lanier ST, Khan SU, Dagum AB, et al. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg. 2011; 66(5): 460-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments